Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2000 Sep;107(9):1671-4.
doi: 10.1016/s0161-6420(00)00263-3.

Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma

Affiliations
Clinical Trial

Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma

F El Sayyad et al. Ophthalmology. 2000 Sep.

Abstract

Objective: To establish the efficacy and safety of nonpenetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma.

Design: Prospective randomized trial.

Participants: Thirty-nine patients (78 eyes) with bilateral primary open angle glaucoma were included in the study.

Intervention: Eyes were randomly assigned to receive deep sclerectomy in one eye and trabeculectomy in the other eye.

Main outcome measures: Mean intraocular pressure (IOP), postoperative medications, visual acuity, success rate, and complications.

Results: At 12 months, mean IOP reduction was 12.3 +/- 4.2 (sclerectomy) versus 14.1 +/- 6.4 mmHg (trabeculectomy) (P = 0.15), and an IOP </= 21 mmHg was achieved in 36 (92.3%) and 37 eyes (94.9%) (P = 0.9), respectively. Complications included three (7.7%) flat/shallow anterior chambers and one (2.6%) hypotony (trabeculectomy), whereas internal iris incarceration was encountered in two eyes (5.1%) (sclerectomy).

Conclusions: Deep sclerectomy may provide comparable IOP reduction with fewer complications in management of primary open angle glaucoma.

PubMed Disclaimer

Comment in

LinkOut - more resources